Skip to content. | Skip to navigation

European Coalition on Homeopathic & Anthroposophic Medicinal Products



A key public health challenge for Europe is to address the issue of inappropriate polypharmacy and non-adherence as the population ages. With a growing cultural reliance on pharmaceutical interventions to manage health conditions, the issue of polypharmacy is becoming increasingly pressing, especially coupled with the increasing prevalence of chronic diseases and multimorbidity. It is common for older adults to be prescribed at least five drugs simultaneously, which in turn increases the risk of adverse drug reactions and side effects.

In tackling these issues, studies justify consideration of the ability of homeopathy and anthroposophic medicine to reduce reliance on conventional drugs. For example, as noted in the EPI-3 studies for sleep, anxiety and depressive disorders, patients treated by certified homeopathic physicians were less likely to be prescribed psychotropic drugs, reducing their usage and avoiding their addictive potential. Similarly, patients with musculoskeletal disorders treated with homeopathy did as well clinically as those treated with conventional medicine but used only half the amount of non-steroidal anti-inflammatory drugs (NSAIDs) and had fewer NSAID-related side effects.

Last updated on 22 May 2019